Hao Wei

Title: Innovations of Hao Wei in Chiral Separation Technologies

Introduction

Hao Wei is a notable inventor based in Nanjing, China, recognized for his contributions to the field of chiral separation technologies. With a focus on resolving racemic mixtures, he has developed innovative methods that enhance the purity and efficacy of pharmaceutical compounds.

Latest Patents

Hao Wei holds two patents related to the resolution of racemic mixtures to obtain (−)-Huperzine A. His methods involve the use of chiral high-performance liquid chromatography (HPLC) to separate (−)-Huperzine A from the racemic mixture of (±)-Huperzine A. The process utilizes a mobile phase that includes a solution of alcohol and dichloromethane, trichloromethane, or a mixture thereof. Additionally, the chiral HPLC employs a chiral stationary phase consisting of a polysaccharide derivative.

Career Highlights

Throughout his career, Hao Wei has worked with various organizations, including Amphastar Pharmaceuticals, Inc. His expertise in chiral separation has made significant impacts in the pharmaceutical industry, particularly in the development of drugs that require high purity levels.

Collaborations

Hao Wei has collaborated with notable colleagues such as Yonggang Xu and Song Chen, contributing to advancements in their shared field of research.

Conclusion

Hao Wei's innovative methods in chiral separation technologies have positioned him as a key figure in the pharmaceutical industry. His work continues to influence the development of effective and pure pharmaceutical compounds.